The frequency of inappropriate nonformulary medication alert overrides in the inpatient setting

Author:

Her Qoua L1,Amato Mary G2,Seger Diane L3,Beeler Patrick E14,Slight Sarah P5,Dalleur Olivia6,Dykes Patricia C7,Gilmore James F8,Fanikos John8,Fiskio Julie M3,Bates David W1

Affiliation:

1. Division of General Internal Medicine and Primary Care, Brigham and Women’s Hospital, 1620 Tremont Street, One Brigham Circle, Harvard Medical School, Boston, MA 02120, USA

2. Department of Pharmacy Practice, MCPHS University, Boston, MA, USA

3. Clinical and Quality Analysis, Information Systems, Partners HealthCare System, Inc., Wellesley, MA, USA

4. Research Center for Medical Informatics, University Hospital Zurich and University of Zurich, Switzerland

5. Wolfson Research Institute, School of Medicine, Pharmacy and Health, Durham University, Queen’s Campus, Stockton-on-Tees, TS17 6BH, UK

6. Louvain Drug Research Institute, Clinical Pharmacy Research Group, Cliniques universitaires Saint-Luc, Université catholique de Louvain, Avenue Mounier 73, B-1200 Brussels, Belgium

7. Center for Patient Safety, Research and Practice, Brigham and Women’s Hospital, Boston, MA, USA

8. Department of Pharmacy Services, Brigham and Women’s Hospital, Boston, MA, USA

Abstract

Abstract Background Experts suggest that formulary alerts at the time of medication order entry are the most effective form of clinical decision support to automate formulary management. Objective Our objectives were to quantify the frequency of inappropriate nonformulary medication (NFM) alert overrides in the inpatient setting and provide insight on how the design of formulary alerts could be improved. Methods Alert overrides of the top 11 ( n  = 206) most-utilized and highest-costing NFMs, from January 1 to December 31, 2012, were randomly selected for appropriateness evaluation. Using an empirically developed appropriateness algorithm, appropriateness of NFM alert overrides was assessed by 2 pharmacists via chart review. Appropriateness agreement of overrides was assessed with a Cohen’s kappa. We also assessed which types of NFMs were most likely to be inappropriately overridden, the override reasons that were disproportionately provided in the inappropriate overrides, and the specific reasons the overrides were considered inappropriate. Results Approximately 17.2% ( n  = 35.4/206) of NFM alerts were inappropriately overridden. Non-oral NFM alerts were more likely to be inappropriately overridden compared to orals. Alerts overridden with “blank” reasons were more likely to be inappropriate. The failure to first try a formulary alternative was the most common reason for alerts being overridden inappropriately. Conclusion Approximately 1 in 5 NFM alert overrides are overridden inappropriately. Future research should evaluate the impact of mandating a valid override reason and adding a list of formulary alternatives to each NFM alert; we speculate these NFM alert features may decrease the frequency of inappropriate overrides.

Publisher

Oxford University Press (OUP)

Subject

Health Informatics

Reference20 articles.

1. ASHP guidelines on the pharmacy and therapeutics committee and the formulary system;Tyler;Am J Health Syst Pharm.,2008

2. Formulary compliance and pharmacy labor costs associated with systematic formulary management strategy;Helmons;Am J Health Syst Pharm.,2014

3. The evaluation of nonformulary prescribing in a community teaching hospital;Pantaleo;PT.,2000

4. Pharmacy costs associated with nonformulary drug requests;Sweet;Am J Health Syst Pharm.,2001

5. ISMP Medication Error Report Analysis;Cohen;Hosp Pharm.,2006

Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3